- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Epilepsy
- Meeting Date: March 2021
- Public Summary Document (PSD) March 2021 PBAC Meeting - (PDF 1237KB)
- Public Summary Document (PSD) March 2021 PBAC Meeting - (Word 268KB)
Eslicarbazepine – March 2021
Eslicarbazepine: Tablet 800 mg; Zebinix®
Last updated
16 July 2021